Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10229496 | 0.82 | ALDH1A1 (0.44) | TDP1GPR35ALDH1A1TSHRGABRA1 | |
| SCHEMBL164758 | 0.80 | MAOB (0.47) | MAOBKDM4EALDH1A1TSHRHTT | |
| SCHEMBL10923400 | 0.79 | TDP1 (0.48) | TDP1GPR35ALDH1A1TSHRHTT | |
| SCHEMBL795687 | 0.78 | KDM4E (0.43) | TDP1KDM4EGPR35ALDH1A1HTT | |
| SCHEMBL286962 | 0.78 | MAOB (0.56) | MAOBALDH1A1TSHRHTTL3MBTL1 | |
| SCHEMBL499373 | 0.77 | GPR35 (0.50) | MAOBTDP1GPR35ALDH1A1TSHR | |
| SCHEMBL8978449 | 0.76 | TSHR (0.44) | TDP1KDM4EGPR35ALDH1A1TSHR | |
| SCHEMBL3258910 | 0.75 | GPR35 (0.51) | TDP1KDM4EGPR35ALDH1A1TSHR | |
| SCHEMBL16401319 | 0.74 | TSHR (0.54) | TDP1KDM4EGPR35ALDH1A1TSHR | |
| SCHEMBL3807003 | 0.74 | KDM4E (0.45) | TDP1KDM4EGPR35ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3664817-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | Phio Pharmaceuticals Corp. (US) | 2020-06-17 | — | — | EP | disclosed |
| WO-2019032619-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES | PHIO PHARMACEUTICALS CORP. (US) | 2019-02-14 | — | — | WO | disclosed |
| EP-3426654-A1 | DIRECT PALLADIUM-CATALYZED AROMATIC FLUORINATION | President and Fellows of Harvard College (US) | 2019-01-16 | — | — | EP | disclosed |
| WO-2018213365-A1 | COMPOUNDS FOR TREATING DENGUE VIRUS INFECTION AND OTHER VIRAL INFECTIONS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-11-22 | — | — | WO | disclosed |
| EP-3383852-A2 | COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | Children's Medical Center Corporation (US) | 2018-10-10 | — | — | EP | disclosed |
| EP-3347018-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASES | Dana-Farber Cancer Institute, Inc. (US) | 2018-07-18 | — | — | EP | disclosed |
| EP-3319614-A1 | NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1) | RXi Pharmaceuticals Corporation (US) | 2018-05-16 | — | — | EP | disclosed |
| WO-2017156265-A1 | DIRECT PALLADIUM-CATALYZED AROMATIC FLUORINATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-09-14 | — | — | WO | disclosed |
| WO-2017095950-A2 | COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2017-06-08 | — | — | WO | disclosed |
| WO-2017044858-A2 | INHIBITORS OF CYCLIN-DEPENDENT KINASES | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-03-16 | — | — | WO | disclosed |
| EP-2582836-A2 | PRPK-TPRKB MODULATORS AND USES THEREOF | Makoto Life Sciences, Inc. (US) | 2013-04-24 | — | — | EP | disclosed |
| WO-2012075277-A2 | SYNTHETIC METHODS | NOVOMER, INC. (US) | 2012-06-07 | — | — | WO | disclosed |
| WO-2012037282-A2 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012015691-A2 | RECOMBINANT LECTINS, BINDING-SITE MODIFIED LECTINS AND USES THEREOF | SMARTCELLS, INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| WO-2011160042-A2 | PRPK-TPRKB MODULATORS AND USES THEREOF | MAKOTO LIFE SCIENCES, INC. (US) | 2011-12-22 | — | — | WO | disclosed |
| WO-2009042972-A9 | FLUORINATED LIPIDS AND METHODS OF USE | TUFTS UNIVERSITY (US) | 2011-02-03 | — | — | WO | disclosed |
| EP-1753713-A4 | SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF | HARVARD COLLEGE (US) | 2009-07-08 | — | — | EP | disclosed |
| WO-2009042972-A1 | FLUORINATED LIPIDS AND METHODS OF USE | TUFTS UNIVERSITY (US) | 2009-04-02 | — | — | WO | disclosed |
| EP-1753713-A2 | SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF | The President and Fellows of Harvard College (US) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005112945-A2 | SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-12-01 | — | — | WO | disclosed |